Deferred Income Tax Assets, Net of SINOVAC BIOTECH LTD from 31 Dec 2019 to 31 Dec 2023

Taxonomy & unit: us-gaap: USD
Description: Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary: SINOVAC BIOTECH LTD quarterly Deferred Income Tax Assets, Net in USD history and change rate from 31 Dec 2019 to 31 Dec 2023.
SINOVAC BIOTECH LTD Deferred Income Tax Assets, Net for the quarter ending 31 Dec 2023 was $29,790,000, a 58% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Income Tax Assets, Net, Quarterly (USD)

Deferred Income Tax Assets, Net, YoY Quarterly Change (%)

SINOVAC BIOTECH LTD Quarterly Deferred Income Tax Assets, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2023	$29,790,000	-$41,328,000	-58%	31 Dec 2023	20-F	29 Apr 2024	2023	FY
Q4 2022	$71,118,000	+$19,087,000	+37%	31 Dec 2022	20-F	29 Apr 2024	2023	FY
Q4 2021	$52,031,000	+$25,140,000	+93%	31 Dec 2021	20-F	01 May 2023	2022	FY
Q4 2020	$26,891,000	+$15,523,000	+137%	31 Dec 2020	20-F	29 Apr 2022	2021	FY
Q4 2019	$11,368,000			31 Dec 2019	20-F	22 Apr 2021	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.